Hydrogen and health / Research review
Hydrogen and the joints: rheumatoid arthritis
In rheumatoid arthritis, the authors of two Japanese studies, one of them double-blind, observed lower disease activity in the hydrogen groups.
Covers
Studies
Human studies: 2 studies in the cards below, including 1 randomised.
How hydrogen was given
Inhalation, hydrogen water, other route.
On this page
Joints: key findings from the studies
- RA, infusions with hydrogen (24 people, double-blind): a fall in the DAS28 index from 5.18 to 4.02 and in the IL-6 level by 37%.
- RA, hydrogen water (20 people): a fall in DAS28 from 3.83 to 3.02 after 4 weeks.
Hydrogen and rheumatoid arthritis (RA)
In an open-label study, 20 people drank hydrogen water in two 4-week cycles1. The DAS28 disease activity index fell from 3.83 to 3.02 after the first cycle. Participants continued their medication; the study had no placebo group.
In the next study, this time double-blind, 12 people received an infusion of saline with hydrogen for 5 days, and 12 an infusion without hydrogen2. DAS28 fell from 5.18 to 4.02, and the IL-6 level decreased by 37%, while in the placebo group it rose. An intravenous infusion is a hospital procedure.
Hydrogen and joints: the studies we refer to
Click an entry to see who took part in the study, how hydrogen was given and what the result was.
What the studies say
Selected scientific publications on molecular hydrogen in humans: a description of each study, its results and a link to the source.
1Rheumatoid arthritis, H2 water
Hydrogen waterno control groupn = 202012
Rheumatoid arthritis, H2 water
- Participants
- People with RA, including 5 with an early form without ACPA
- Protocol
- 530 ml/day of H2 water at 4–5 ppm, 4 weeks, a 4-week break and another 4 weeks
- Result
- DAS28 fell from 3.83 to 3.02 after the first cycle (p<0.01); 8-OHdG by 14.3%. After the second cycle, DAS28: 2.83→2.26.
- Study context
- Open-label before–after study without a control. Participants: 20.
Ishibashi T i wsp.. Consumption of water containing a high concentration of molecular hydrogen reduces oxidative stress and disease activity in patients with rheumatoid arthritis: an open-label pilot study. Medical gas research 2(1): 27. 2012. PubMed 23031079 · DOI · Full text
2Rheumatoid arthritis, intravenous H2
Infusionrandomised trialn = 242014
Rheumatoid arthritis, intravenous H2
- Participants
- 12 H2 and 12 placebo
- Protocol
- 500 ml of saline with H2 at 1 ppm/day for 5 days; follow-up at 4 weeks
- Result
- DAS28 in the H2 group: 5.18→4.02 immediately after the infusions and 3.74 after 4 weeks. IL-6: −37.3% vs +33.6% with placebo; MMP-3: −19.2% vs +16.9%.
- Study context
- Pilot RCT, double-blind. Participants: 24.
Ishibashi T i wsp.. Therapeutic efficacy of infused molecular hydrogen in saline on rheumatoid arthritis: a randomized, double-blind, placebo-controlled pilot study. International immunopharmacology 21(2): 468-473. 2014. PubMed 24929023 · DOI
Educational information, not medical advice. Full database of publications: Hydrogen Studies.
Joints: topics in this area
Joints and hydrogen: frequently asked questions
How was hydrogen given in the joint studies?
In rheumatoid arthritis, participants drank 530 ml of hydrogen water a day in two 4-week cycles, or received an infusion of saline with hydrogen in hospital for 5 days.
Did participants keep taking their medication during the studies?
Yes. In the rheumatoid arthritis studies participants continued their existing medication and hydrogen was an addition.
Is it a medical device?
No. PRAGMA HYDROGEN is a device for wellness use. It does not replace a consultation with a doctor.
Is hydrogen inhalation safe?
In clinical trials, hydrogen inhalation was well tolerated. The generator has 8 safety features that stop it working if a fault occurs. Hydrogen is a flammable gas: do not smoke or use an open flame near the device. People with chronic conditions, pregnant women and children should consult a doctor before use.